Intravitreal injection of anti-vascular endothelial growth factor agents for ocular vascular diseases: Clinical practice guideline.

Purpose: To provide the clinical recommendations for the administration of intravitreal anti-vascular endothelial growth factor (VEGF) drugs especially bavacizumab for ocular vascular diseases including diabetic macular edema, neovascular age-related macular degeneration, myopic choroidal neovascula...

Descripción completa

Detalles Bibliográficos

Publicado en:	Journal of Ophthalmic & Vision Research Vol. 13; no. 2; pp. 158 - 170
Autores principales:	Nikkhah, Homayoun, Karimi, Saeed, Ahmadieh, Hamid, Azarmina, Mohsen, Abrishami, Majid, Ahoor, Hossein, Alizadeh, Yousef, Behboudi, Hasan, Daftarian, Narsis, Dehghan, Mohammad, Entezari, Morteza, Farrahi, Fereydoun, Ghanbari, Heshmatollah, Falavarjani, Khalil, Javadi, Mohammad, Karkhaneh, Reza, Moradian, Siamak, Manaviat, Masoud, Mehryar, Morsal, Nourinia, Ramin
Formato:	practice guidelines tables/charts Journal Article
Publicado:	Knowledge E DMCC Apr-Jun2018
Acceso en línea:	Ver este registro en EBSCOhost